Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors

Carbohydrate antigen 19-9 (CA19-9) is not generally considered to be a biomarker in pancreatic neuroendocrine tumors (pNETs), as the majority of pNETs present with a normal range of CA19-9. The present study aimed to evaluate the role of serum CA19-9 levels as a prognostic factor in a relatively lar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Luo, Guopei, Jin, Kaizhou, Cheng, He, Liu, Chen, Guo, Meng, Lu, Yu, Yang, Chao, Xu, Jinzhi, Wang, Wenquan, Gao, Heli, Zhang, Shirong, Long, Jiang, Xu, Jin, Ni, Quanxing, Chen, Jie, Yu, Xianjun
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2017
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688789/
https://ncbi.nlm.nih.gov/pubmed/29163700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7071
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares